News 18 November 2026 Foundayo approval a welcome addition to GLP-1 treatment options Diabetes Australia has welcomed the TGA approval of Foundayo (orforglipron), a new oral GLP-1 receptor agonist for the management of type 2 diabetes and chronic weight management in eligible adults. Continue Reading
News 17 November 2026 All PolliePedal funds to stay in Tasmania permanently to support local people living with diabetes Continue Reading
News 6 November 2026 Diabetes Australia welcomes new oral GLP-1 treatment option for Australians Continue Reading
News 15 October 2026 Resilience and strength of Nhulunbuy man recognised with Kellion Victory Medal Continue Reading